Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 18 June 2026Incoming appointee
4 itemsScheduled Appointment DateEffective 1 July 2026. The changes in officers and the duties assigned to executive officers are scheduled to be formally decided at the annual general meeting of shareholders and the Board of Directors meeting scheduled for 25 June 2026.
Naito Shigemi (内藤 茂美)
Previous positionDirector and Managing Executive Officer, General Manager of the Administration Headquarters, responsible for receivables management and CSR
New positionDirector and Senior Managing Executive Officer, General Manager of the Administration Headquarters, responsible for receivables management and CSR
Yamaguchi Soichi (山口 聡一)
Previous positionDirector and Managing Executive Officer, President and Representative Director of 株式会社医療経営研究所, and responsible for medical information planning
New positionDirector and President and Representative Director of 株式会社医療経営研究所
Kato Keiichi (加藤 圭一)
Previous positionExecutive Officer and Deputy General Manager of the Sales Headquarters, General Manager of the Distribution and Regional Access Department
New positionExecutive Officer, Deputy General Manager of the Sales Headquarters and General Manager of the Distribution Management Department
Kobayashi Yuichi (小林 右一)
Previous positionExecutive Officer, responsible for business development
New positionExecutive Officer, responsible for business development and medical information planning
Departing officer
1 itemDate of departureEffective 30 June 2026
Maeda Tetsuro (前田 哲郎)Next role stated
Former PositionExecutive Officer and General Manager reporting to the President (General Manager of the Baseball Club)
New positionAdviser. He is scheduled to continue serving as General Manager reporting to the President (General Manager of the Baseball Club).
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
He will not remain on the Board of Directors. He is scheduled to continue serving as General Manager reporting to the President (General Manager of the Baseball Club).
Shareholders’ meeting approvalRequired. The changes are scheduled to be formally decided at the annual general meeting of shareholders and the Board of Directors meeting scheduled for 25 June 2026.
Details of organizational changes
The "Management Strategy" function within the President's Office will be changed to the "Management Strategy and AX Promotion" function., The "Distribution and Regional Access Department" will be changed to the "Distribution Management Department.", The "Regional Healthcare Coordination" function will be changed to the "Government Relations Coordination" function., The "Marketing," "Inside Wellness" and "Wellness" functions will be consolidated into the "Life Support" function., The "LIME" function will be changed to the "EC" function.
| Item | Details |
|---|---|
| Resolution date | 18 June 2026 |
| Scheduled Appointment Date | Effective 1 July 2026. The changes in officers and the duties assigned to executive officers are scheduled to be formally decided at the annual general meeting of shareholders and the Board of Directors meeting scheduled for 25 June 2026. |
| Date of departure | Effective 30 June 2026 |
| Name of appointee | Naito Shigemi (内藤 茂美), Yamaguchi Soichi (山口 聡一), Kato Keiichi (加藤 圭一), Kobayashi Yuichi (小林 右一) |
| Appointee's new position | Director and Senior Managing Executive Officer, General Manager of the Administration Headquarters, responsible for receivables management and CSR, Director and President and Representative Director of 株式会社医療経営研究所, Executive Officer, Deputy General Manager of the Sales Headquarters and General Manager of the Distribution Management Department, Executive Officer, responsible for business development and medical information planning |
| Appointee's previous position | Director and Managing Executive Officer, General Manager of the Administration Headquarters, responsible for receivables management and CSR, Director and Managing Executive Officer, President and Representative Director of 株式会社医療経営研究所, and responsible for medical information planning, Executive Officer and Deputy General Manager of the Sales Headquarters, General Manager of the Distribution and Regional Access Department, Executive Officer, responsible for business development |
| Name of departing officer | Maeda Tetsuro (前田 哲郎) |
| Former position of departing officer | Executive Officer and General Manager reporting to the President (General Manager of the Baseball Club) |
| New position of departing officer | Adviser. He is scheduled to continue serving as General Manager reporting to the President (General Manager of the Baseball Club). |
| Whether the incumbent will remain in office | He will not remain on the Board of Directors. He is scheduled to continue serving as General Manager reporting to the President (General Manager of the Baseball Club). |
| Details of organizational changes | The "Management Strategy" function within the President's Office will be changed to the "Management Strategy and AX Promotion" function., The "Distribution and Regional Access Department" will be changed to the "Distribution Management Department.", The "Regional Healthcare Coordination" function will be changed to the "Government Relations Coordination" function., The "Marketing," "Inside Wellness" and "Wellness" functions will be consolidated into the "Life Support" function., The "LIME" function will be changed to the "EC" function. |
| Subject to Approval by the General Meeting of Shareholders | Required. The changes are scheduled to be formally decided at the annual general meeting of shareholders and the Board of Directors meeting scheduled for 25 June 2026. |
Items this document does not state (9)
Appointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To promote company-wide business transformation using AI as a management strategy. No specific reasons are stated for the other personnel changes.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.